JNCCN-360

Editor:

David S. Ettinger, MD

Advertisement

Advertisement

Karen Reckamp, MD, on Metastatic NSCLC: Targeted Treatment Updates

Mark G. Kris, MD, on NSCLC: Juggling Sequence and Agent Choices

A Patient’s Story: How NCCN Guidelines for Patients® Helped Me and My Caregiver

Recent

Are Lung Cancer Screening Guidelines Adequate for High-Risk Minorities?

IASLC Unveils Comprehensive Assessment of Liquid Biopsy for Patients With NSCLC

Can Simplified Screening Methods Accurately Indicate Pathology in NSCLC?

World Lung Cancer Day Commemorated by International Respiratory Societies

Published

Medical Literature

Addition of Biomarker Panel to Lung Cancer Screening: Can It Improve Detection of Disease?

Retrospective Analysis of Brain Metastases in Patients With Stage IV NSCLC

Does Prior Antibiotic Use Affect Treatment Outcomes in Lung Cancer?

Brigatinib Active in Patients With ALK-Positive Lung Cancer

Ongoing

NCCN Pharmacy Updates: The Evolving Landscape of Immunotherapy and Targeted Therapy for Non–Small Cell Lung Cancer

Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Non-Small Cell Lung Cancer

Sustaining Change in Quality Improvement for NSCLC – Part 3

The Emerging Role of Molecular Testing in an Era of Precision Medicine - Non–Small Cell Lung Cancer

Available

Clinical Trials

Fred and Pamela Buffett Cancer Center

Mayo Clinic Cancer Center

University of Wisconsin Carbone Cancer Center

University of Colorado Cancer Center

Sections

NCCN Resources

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.